MYC-associated transcriptional machinery (MYC complex) (MYC complex)

The MYC-associated transcriptional machinery is a multi-protein assembly centered around the MYC family of transcription factors (c-Myc, N-Myc, and L-Myc), which function as master regulators of cellular programs. This machinery primarily operates through the heterodimerization of MYC with its partner MAX, allowing the complex to bind to E-box sequences in the promoters and enhancers of thousands of target genes (Dalla-Favera et al., Nature, 1982; Meyer & Penn, Nature Reviews Cancer, 2008). Beyond DNA binding, the machinery recruits various co-activators, such as TRRAP, p300/CBP, and the Bromodomain and Extra-Terminal (BET) protein BRD4, to facilitate chromatin remodeling and transcriptional elongation (Kuo et al., Nature, 1996; Delmore et al., Cell, 2011). In human cancers, dysregulation of this machinery is a hallmark of malignancy, driving uncontrolled cell proliferation, metabolic shifts, and immune evasion (Gabay et al., Cold Spring Harbor Perspectives in Medicine, 2014). While MYC itself has historically been considered undruggable due to its disordered structure, modern therapeutic approaches target the machinery by disrupting protein-protein interactions or inhibiting the epigenetic readers and kinases essential for its function (Whitfield et al., Frontiers in Cell and Developmental Biology, 2017). Drugs like BET inhibitors and CDK9 inhibitors have shown promise in preclinical and early clinical trials by effectively silencing the MYC-driven transcriptional program (Delmore et al., Cell, 2011). However, the essential role of MYC in normal regenerative tissues presents a significant challenge for achieving a wide therapeutic window (Duffy et al., Molecular Oncology, 2021).

Other names

MYC-MAX complexMYC transcriptional apparatusMYC-driven transcriptional networkMYC-MAX-MXD network

The machinery is targeted through several strategies: disrupting the MYC-MAX heterodimerization required for DNA binding, inhibiting BET bromodomain proteins (like BRD4) that recruit the machinery to chromatin, and blocking kinases such as CDK9 that are essential for MYC-mediated transcriptional elongation (Soucek et al., Nature, 2008; Delmore et al., Cell, 2011; Wang et al., Journal of Medicinal Chemistry, 2018).